Philips Medical Systems North America of Shelton, CT, has received Food and Drug Administration clearance for a new MRI upgrade package that includes high-end features such as cardiac scanning protocols and neuro imaging techniques. The package is
Philips Medical Systems North America of Shelton, CT, has received Food and Drug Administration clearance for a new MRI upgrade package that includes high-end features such as cardiac scanning protocols and neuro imaging techniques. The package is available on the companys Gyroscan NT line of magnets.
In the neuro imaging realm, the new package includes an option supporting diffusion, perfusion, and functional brain imaging, which can help in the early detection of stroke. On the cardiac side, the package enables a Gyroscan NT site to conduct cardiac MRI without purchasing additional hardware. One feature of the package, MotionTrak, enables users to control motion artifacts through gating and slice tracking. Other features of the new package include advancements in MR angiography, MR spectroscopy, and coil technology.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.